Park Ha Biological Technology Co., Ltd.
PHH
$0.4785
$0.00050.11%
NASDAQ
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 42.65% | 17.06% | -3.14% | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 42.65% | 17.06% | -3.14% | -- | -- |
| Cost of Revenue | -45.18% | -40.99% | -37.17% | -- | -- |
| Gross Profit | 57.70% | 26.13% | 1.78% | -- | -- |
| SG&A Expenses | 2,006.58% | 1,069.58% | 44.77% | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1,522.65% | 791.67% | 24.21% | -- | -- |
| Operating Income | -3,278.57% | -1,124.31% | -32.76% | -- | -- |
| Income Before Tax | -3,274.28% | -1,121.10% | -32.85% | -- | -- |
| Income Tax Expenses | 129.05% | 45.34% | -4.49% | -- | -- |
| Earnings from Continuing Operations | -4,937.09% | -1,610.36% | -43.83% | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4,937.09% | -1,610.36% | -43.83% | -- | -- |
| EBIT | -3,278.57% | -1,124.31% | -32.76% | -- | -- |
| EBITDA | -3,165.42% | -1,098.40% | -32.00% | -- | -- |
| EPS Basic | -4,603.75% | -1,502.80% | -43.53% | -- | -- |
| Normalized Basic EPS | -3,029.33% | -1,040.36% | -32.43% | -- | -- |
| EPS Diluted | -4,603.75% | -1,502.80% | -43.53% | -- | -- |
| Normalized Diluted EPS | -3,029.33% | -1,040.36% | -32.43% | -- | -- |
| Average Basic Shares Outstanding | 3.77% | 1.89% | 0.00% | -- | -- |
| Average Diluted Shares Outstanding | 3.77% | 1.89% | 0.00% | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |